Table 1 Clinical characteristics and laboratory tests of the primary cohort and validation cohort
Clinical characteristics | Primary cohort (n = 239) | Validation cohort (n = 59) | P value |
|---|---|---|---|
Age, mean ± SD | 46.30 ± 15.90 | 45.64 ± 16.57 | 0.614 |
Gender | |||
Male | 134 (56.07%) | 31 (52.54%) | 0.733 |
Female | 105 (43.93%) | 28 (47.46%) | |
Epidemiological history | |||
Direct contact | 69 (28.87%) | 19 (32.20%) | 0.546 |
Indirect contact | 42 (17.57%) | 13 (22.03%) | |
None contact | 128 (53.55%) | 27 (45.76%) | |
Symptom | |||
Fever | 168 (70.29%) | 47 (79.66%) | 0.202 |
Cough | 106 (44.35%) | 31 (52.54%) | 0.097 |
Chest distress | 27 (11.30%) | 6 (10.17%) | 0.988 |
Diarrhea | 5 (2.09%) | 5 (8.47%) | 0.042* |
Anorexia | 5 (2.09%) | 1 (1.69%) | 1.000 |
Laboratory Test, median (inter-quartile range) | |||
WBC, median (range), × 109/L | 5.28 (4.30–10.44) | 5.96 (3.91–6.00) | 0.101 |
Lymphocyte count, median (range), × 109/L | 1.19 (0.90–1.63) | 1.21 (0.85–1.44) | 0.746 |
LDH, median (range), U/L | 233.00 (193.00–271.40) | 234 (199–290) | 0.158 |
CRP, median (range), mg/L | 14.80 (4.8–42.93) | 25.90 (3.7–30.30) | 0.038* |
PCT, median (range), ng/mL | 0.05 (0–0.19) | 0.04 (0.02–0.06) | 0.743 |
ALT, median (range), U/L | 30.00 (20.00–51.50) | 29.90 (17.30–37.70) | 0.558 |
AST, median (range), U/L | 28.00 (21.00–46.75) | 28.00 (20.40–34.70) | 0.450 |